Chemoradiation in elderly esophageal cancer patients: rationale and design of a phase I/II multicenter study (OSAGE)

por Servagi-Vernat, Stéphanie, Créhange, Gilles, Bonnetain, Franck, Mertens, Cécile, Brain, Etienne, Bosset, Jean François
Publicado 2017

Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International Survey

por Frelaut, Maxime, De Glas, Nienke, Zapardiel, Ignacio, Kaidar-Person, Orit, Kfoury, Maria, You, Benoit, Banerjee, Susana, Brain, Etienne, Falandry, Claire, Rodrigues, Manuel
Publicado 2019

Taking care of older patients with cancer in the context of COVID-19 pandemic

por Mourey, Loïc, Falandry, Claire, de Decker, Laure, Boulahssass, Rabia, Carola, Elisabeth, Bengrine Lefevre, Leila, Cudennec, Tristan, Brain, Etienne, Paillaud, Eléna, Soubeyran, Pierre
Publicado 2020

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

por Brignone, Chrystelle, Gutierrez, Maya, Mefti, Fawzia, Brain, Etienne, Jarcau, Rosana, Cvitkovic, Frédérique, Bousetta, Nabil, Medioni, Jacques, Gligorov, Joseph, Grygar, Caroline, Marcu, Manon, Triebel, Frédéric
Publicado 2010

Assessment of circulating tumor cells and serum markers for progression-free survival prediction in metastatic breast cancer: a prospective observational study

por Bidard, François-Clément, Hajage, David, Bachelot, Thomas, Delaloge, Suzette, Brain, Etienne, Campone, Mario, Cottu, Paul, Beuzeboc, Philippe, Rolland, Emilie, Mathiot, Claire, Pierga, Jean-Yves
Publicado 2012

Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survival

por Rochefort, Pauline, Chabaud, Sylvie, Pierga, Jean-Yves, Tredan, Olivier, Brain, Etienne, Bidard, François-Clément, Schiffler, Camille, Polena, Helena, Khalil-Mgharbel, Abir, Vilgrain, Isabelle, Bachelot, Thomas
Publicado 2017

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2...

por Wildiers, Hans, Meyskens, Thomas, Marréaud, Sandrine, Lago, Lissandra Dal, Vuylsteke, Peter, Curigliano, Giuseppe, Waters, Simon, Brouwers, Barbara, Meulemans, Bart, Sousa, Berta, Poncet, Coralie, Brain, Etienne
Publicado 2022

A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer

por Janni, Wolfgang, Sarosiek, Tomasz, Karaszewska, Boguslawa, Pikiel, Joanna, Staroslawska, Elzbieta, Potemski, Piotr, Salat, Christoph, Brain, Etienne, Caglevic, Christian, Briggs, Kathryn, DeSilvio, Michelle, Marini, Luca, Papadimitriou, Christos
Publicado 2014

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated...

por Sabatier, Renaud, Diéras, Véronique, Pivot, Xavier, Brain, Etienne, Roché, Henri, Extra, Jean-Marc, Monneur, Audrey, Provansal, Magali, Tarpin, Carole, Bertucci, François, Viens, Patrice, Zemmour, Christophe, Gonçalves, Anthony
Publicado 2018

Perspectives on cancer care in older patients in France

por Hauchecorne, Mathilde, Pierro, Monica, Brain, Etienne, Bringuier, Michael, Soubeyran, Pierre, Chakiba, Camille, Mathoulin-Pelissier, Simone, Paillaud, Elena, Geiss, Romain, Besse, Benjamin, Mourey, Loïc, Vincent, Hélène, Baldini, Capucine
Publicado 2020

Clinical utility of circulating tumour cell-based monitoring of late-line chemotherapy for metastatic breast cancer: the randomised CirCe01 trial

por Cabel, Luc, Berger, Frédérique, Cottu, Paul, Loirat, Delphine, Rampanou, Aurore, Brain, Etienne, Cyrille, Stacy, Bourgeois, Hugues, Kiavue, Nicolas, Deluche, Elise, Ladoire, Sylvain, Campone, Mario, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicado 2021

Plasma thymidine kinase 1 activity and outcome of ER+ HER2− metastatic breast cancer patients treated with palbociclib and endocrine therapy

por Cabel, Luc, Rosenblum, Dan, Lerebours, Florence, Brain, Etienne, Loirat, Delphine, Bergqvist, Mattias, Cottu, Paul, Donnadieu, Anne, Bethune, Anne, Kiavue, Nicolas, Rodrigues, Manuel, Pierga, Jean-Yves, Tanguy, Marie-Laure, Bidard, François-Clément
Publicado 2020

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

por López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Publicado 2020

Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial

por Jacot, William, Cottu, Paul, Berger, Frederique, Dubot, Coraline, Venat-Bouvet, Laurence, Lortholary, Alain, Bourgeois, Hugues, Bollet, Marc, Servent, Veronique, Luporsi, Elisabeth, Espié, Marc, Guiu, Severine, D’Hondt, Veronique, Dieras, Veronique, Sablin, Marie-Paule, Brain, Etienne, Neffati, Souhir, Pierga, Jean-Yves, Bidard, Francois-Clement
Publicado 2019

Impact of BRCA Mutation Status on Tumor Infiltrating Lymphocytes (TILs), Response to Treatment, and Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

por Grandal, Beatriz, Evrevin, Clémence, Laas, Enora, Jardin, Isabelle, Rozette, Sonia, Laot, Lucie, Dumas, Elise, Coussy, Florence, Pierga, Jean-Yves, Brain, Etienne, Saule, Claire, Stoppa-Lyonnet, Dominique, Frank, Sophie, Sénéchal, Claire, Lae, Marick, De Croze, Diane, Bataillon, Guillaume, Guerin, Julien, Reyal, Fabien, Hamy, Anne-Sophie
Publicado 2020

Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts

por Oubaya, Nadia, Soubeyran, Pierre, Reinald, Nicoleta, Fonck, Marianne, Allain, Mylène, Zebachi, Sonia, Heitz, Damien, Laurent, Marie, Delattre, Cécile, Caillet, Philippe, Dauba, Jérôme, Bastuji-Garin, Sylvie, Albrand, Gilles, Bringuier, Michael, Rainfray, Muriel, Brain, Etienne, Grellety, Thomas, Paillaud, Elena, Mathoulin-Pélissier, Simone, Bellera, Carine, Canouï-Poitrine, Florence
Publicado 2021

VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicance...

por Gal, Jocelyn, Milano, Gérard, Brest, Patrick, Ebran, Nathalie, Gilhodes, Julia, Llorca, Laurence, Dubot, Coraline, Romieu, Gilles, Desmoulins, Isabelle, Brain, Etienne, Goncalves, Anthony, Ferrero, Jean-Marc, Cottu, Paul-Henri, Debled, Marc, Tredan, Olivier, Chamorey, Emmanuel, Merlano, Marco Carlo, Lemonnier, Jérôme, Etienne-Grimaldi, Marie-Christine, Pierga, Jean-Yves
Publicado 2020

ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study

por Monti, Manuela, Degenhardt, Tom, Brain, Etienne, Wuerstlein, Rachel, Argusti, Alessandra, Puntoni, Matteo, Rollandi, Gian Andrea, Corradengo, Davide, Boni, Luca, Ilhan, Harun, Nanni, Oriana, Cortes, Javier, Piris-Gimenez, Alejandro, Piccardo, Arnoldo, Iacozzi, Massimiliano, Matteucci, Federica, Di Iorio, Valentina, Alberini, Jean Louis, Schröder, Carolien, Harbeck, Nadia, Gennari, Alessandra
Publicado 2022

Management and outcome of male metastatic breast cancer in the national multicenter observational research program Epidemiological Strategy and Medical Economics (ESME)

por Sirieix, Junien, Fraisse, Julien, Mathoulin-Pelissier, Simone, Leheurteur, Marianne, Vanlemmens, Laurence, Jouannaud, Christelle, Diéras, Véronique, Lévy, Christelle, Ung, Mony, Mouret-Reynier, Marie-Ange, Petit, Thierry, Coudert, Bruno, Brain, Etienne, Pistilli, Barbara, Ferrero, Jean-Marc, Goncalves, Anthony, Uwer, Lionel, Patsouris, Anne, Tredan, Olivier, Courtinard, Coralie, Gourgou, Sophie, Frénel, Jean-Sébastien
Publicado 2020

Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program

por Le Du, Fanny, Carton, Matthieu, Bachelot, Thomas, Saghatchian, Mahasti, Pistilli, Barbara, Brain, Etienne, Loirat, Delphine, Vanlemmens, Laurence, Vermeulin, Thomas, Emile, George, Gonçalves, Anthony, Ung, Mony, Robert, Marie, Jaffre, Anne, Desmoulins, Isabelle, Jouannaud, Christelle, Uwer, Lionel, Marc Ferrero, Jean, Mouret-Reynier, Marie-Ange, Jacot, William, Chevrot, Michaël, Delaloge, Suzette, Diéras, Véronique
Publicado 2023